Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study

Autor: COLLINS, P., FARADJI, A., MORFINI, M., ENRIQUEZ, M.M., SCHWARTZ, L. *
Zdroj: In Journal of Thrombosis and Haemostasis January 2010 8(1):83-89
Databáze: ScienceDirect
Externí odkaz: